Home › Vasculitis › NCT05734404
Longitudinal Study for Central Nervous System Vasculitis
RecruitingObservational study
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: i. Diagnostic criteria for CNSV 1. The presence of an acquired and otherwise unexplained neurologic deficit 2. The presence of either classic angiographic or histopathologic features of angiitis in the CNS 3. No evidence of systemic vasculitis or any condition that could cause the angiographic or pathologic features ii. ≥18 years of age Exclusion Criteria: i. Unwilling to sign informed consent.
About the study
Primary central nervous system vasculitis (CNSV) is a potentially fatal, single-organ vasculitis that often involves a spectrum of neurologic complications, including strokes, cognitive and speech impairment, visual loss, dementia, and encephalopathy. The purpose of this study is to establish a research cohort to investigate the disease process, treatments, and patient outcomes in CNSV.
Sponsor: University of Pennsylvania · Participants: 40 · Started: Mar 1, 2023
Contact the study team
- Carol McAlear · Phone: 7813214567
Official record on ClinicalTrials.gov — NCT05734404
Locations in the U.S.
| Minnesota | Mayo Clinic, Rochester |
| Ohio | Cleveland Clinic, Cleveland |
| Pennsylvania | University of Pennsylvania, Philadelphia |
| Tennessee | Vanderbilt University, Nashville |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.